Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.32B |
| 2 |
D.R. Horton
DHI
|
+$1.01B |
| 3 |
NVIDIA
NVDA
|
+$970M |
| 4 |
Micron Technology
MU
|
+$946M |
| 5 |
Netflix
NFLX
|
+$897M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.73B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.7B |
| 3 |
Apple
AAPL
|
+$1.7B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.54B |
| 5 |
Microsoft
MSFT
|
+$1.22B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.91% |
| 2 | Healthcare | 17.33% |
| 3 | Industrials | 12.86% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Beam Therapeutics
BEAM
$2.75B
| $8.9M | ﹤0.01% |
+227,566
| New | +$10.2M |
|
402
Playtika
PLTK
$919M
| $8.58M | ﹤0.01% |
1,008,409
-1,295,257
| -56% | -$12M |
|
|
JOAN
403
DELISTED
JOANN, Inc. Common Stock
JOAN
| $7.78M | ﹤0.01% |
2,729,250
| – | – |
|
|
PETQ
404
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $7.26M | ﹤0.01% |
787,484
-93,077
| -11% | -$869K |
|
405
Semtech
SMTC
$12.7B
| $6.93M | ﹤0.01% |
241,587
-433,413
| -64% | -$12.3M |
|
406
BARK
BARK
$95.4M
| $6.71M | ﹤0.01% |
225,000
+100,000
| +80% | +$3.33M |
|
407
Health Catalyst
HCAT
$132M
| $6.05M | ﹤0.01% |
568,785
| – | – |
|
408
Procore
PCOR
$8.69B
| $5.93M | ﹤0.01% |
125,600
| – | – |
|
409
LivePerson
LPSN
$34.8M
| $4.72M | ﹤0.01% |
31,007
-25,667
| -45% | -$4.11M |
|
410
XP
XP
$8.03B
| $4.48M | ﹤0.01% |
292,000
| – | – |
|
411
CEVA Inc
CEVA
$873M
| $4.48M | ﹤0.01% |
175,000
| – | – |
|
412
Ryanair
RYAAY
$30.7B
| $4.4M | ﹤0.01% |
147,215
-1,488,055
| -91% | -$42.3M |
|
413
UiPath
PATH
$7.79B
| $4.13M | ﹤0.01% |
+325,000
| New | +$4.02M |
|
414
Strategy Inc
MSTR
$37.9B
| $4.11M | ﹤0.01% |
290,040
-271,240
| -48% | -$5.54M |
|
415
JFrog
FROG
$10.9B
| $3.81M | ﹤0.01% |
178,400
| – | – |
|
416
Sony
SONY
$137B
| $3.49M | ﹤0.01% |
227,840
-13,130
| -5% | -$196K |
|
417
TSMC
TSM
$2.24T
| $3.35M | ﹤0.01% |
44,115
+6,122
| +16% | +$443K |
|
418
Ares Management
ARES
$32.5B
| $3.13M | ﹤0.01% |
45,670
| – | – |
|
419
ASML
ASML
$712B
| $3.02M | ﹤0.01% |
5,468
-377
| -6% | -$197K |
|
|
NVO
420
Novo Nordisk
NVO
$201B
| $2.99M | ﹤0.01% |
+44,252
| New | +$2.59M |
|
421
Schrodinger
SDGR
$1.39B
| $2.89M | ﹤0.01% |
154,790
+123,540
| +395% | +$2.56M |
|
422
Rapid7
RPD
$860M
| $2.42M | ﹤0.01% |
71,250
| – | – |
|
423
Woodside Energy
WDS
$43.4B
| $2.07M | ﹤0.01% |
86,464
-4,172
| -5% | -$98.9K |
|
424
Organon & Co
OGN
$3.6B
| $1.99M | ﹤0.01% |
71,425
| – | – |
|
425
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $1.84M | ﹤0.01% |
4,787
+2,424
| +103% | +$932K |
|
Similar funds
Capital Research Global Investors's Q4 2022 Portfolio in Review
As of Q4 2022, Capital Research Global Investors held 466 positions worth $331B, up 8.7% from $304B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q4 2022 filing shows 37 new, 178 increased, 165 reduced and 30 closed positions. Its largest new stake was Boeing: 8,097,785 shares worth $1.54B. The largest sale was Amazon, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.
- Capital Research Global Investors's largest Q4 2022 buy was Boeing: 8,097,785 shares worth $1.54B.
- Capital Research Global Investors added most to D.R. Horton in Q4 2022, an estimated $1.01B increase.
- Capital Research Global Investors's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.73B.
- Capital Research Global Investors fully exited SVB Financial Group in Q4 2022, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $331B portfolio in Q4 2022.
- Capital Research Global Investors opened 37 new positions and closed 30 in Q4 2022.
- Capital Research Global Investors's portfolio value rose 8.7% quarter-over-quarter to $331B.
Based on Capital Research Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.